Skip to content

Evaluation of the Analgesic Effect of Direct Current Stimulation in the Treatment of Pelvic Pain, Comparing Three Groups: Trans-spinal Stimulation, Ganglionic Stimulation, and Placebo. A Randomized Double-blind Study

Not yet recruitingNot applicableNCT07237165
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to evaluate the analgesic effectiveness of direct current stimulation (tsDCS) in the treatment of pelvic pain by comparing three groups: * Trans-spinal tsDCS stimulation, * Ganglionic tsDCS stimulation, * Placebo (sham) tsDCS stimulation.

Study details

Official title
Evaluation of the Analgesic Effect of Direct Current Stimulation in the Treatment of Pelvic Pain, Comparing Three Groups: Trans-spinal Stimulation, Ganglionic Stimulation, and Placebo. A Randomized Double-blind Study
Interventions
  • Device: Non-invasive device-based neuromodulation
Sponsor
University Hospital, Grenoble
Start date
2025-12-01
Primary completion
2028-11-01
Sex
All
Age range
from 18 Years to 85 Years
Results posted
No results posted in this snapshot
Countries
France
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient aged 18 to 85 years, suffering from pelvic pain for more than one year (excluding musculoskeletal causes). * Patient with stable ongoing medication (analgesic or otherwise) for at least one month. * Patient for whom lack of response to conventional treatments has led the pain specialist or referring physician to consider non-pharmacological therapeutic options. * Patient reporting a pain intensity score \>3 on the Numeric Visual Pain Scale (NVPS) during pre-screening. * Patient affiliated with the national health insurance system or an equivalent scheme. * Patient who has provided written informed consent. Exclusion Criteria: * History of drug addiction. * History of psychiatric disorders likely to interfere with the proper conduct of the study. * Patient with skin lesions in the lumbar region. * Person unable to understand the study protocol. * Individuals covered by Articles L1121-5 to L1121-8 of the French Public Health Code, corresponding to all protected persons: pregnant women, women in labor, breastfeeding mothers, individuals deprived of liberty by judicial or administrative decision, or under legal protection. * Subject currently in the exclusion period of another clinical trial

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07237165